Tag: Pancreatic Cancer Drugs

Blog
With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth over the coming years, claims Roots Analysis

With over 20 approved products and several under development,...

In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based...